Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

Ahmadzadehfar, Hojjat; Rahbar, Kambiz; Baum, Richard P.; Seifert, Robert; Kessel, Katharina; Bogemann, Martin; Kulkarni, Harshad R.; Zhang, Jingjing; Gerke, Carolin; Fimmers, Rolf; Kratochwil, Clemens; Rathke, Hendrik; Ilhan, Harun; Maffey-Steffan, Johanna; Sathekge, Mike Machaba; Kabasakal, Levent; Osvaldo Garcia-Perez, Francisco; Kairemo, Kalevi; Maharaj, Masha; Paez, Diana; Virgolini, Irene
URI: http://hdl.handle.net/2263/78552
Date: 2021-01

Abstract:

Please read abstract in the article.

Description:

This article is part of the Topical Collection on Oncology - Genitourinary

Show full item record

Files in this item

Icon
Name: Ahmadzadehfar_Pri ...
Size: 908.0Kb
Format: PDF
Description: Article
View/Open

This item appears in the following Collection(s)